Neurotoxicology. 1995 Fall;16(3):527-9.

Sulfate and cysteine levels in the plasma of patients with Parkinson's disease.

Allain P, Le Bouil A, Cordillet E, Le Quay L, Bagheri H, Montastruc JL.

Source

Laboratoire de Pharmacologie et Toxicologie, Centre Hospitalier Universitaire, Angers, France.

Abstract

The study of Heafield et al. (1990) has prompted us to compare the levels of sulfate cysteine and homocysteine in the plasma of healthy subjects and of patients with Parkinson's disease treated by L-Dopa and dopa decarboxylase inhibitors. The levels of sulfate and cysteine in the plasma of controls and patients with Parkinson's disease were not statistically different but the level of homocysteine was higher in patients.

PMID:: 8584284; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Medical

Parkinson's Disease - MedlinePlus Health Information

Molecular Biology Databases

CYSTEINE - HSDB

Supplemental Content

Save items

Related citations in PubMed

Elevated plasma levels of homocysteine in Parkinson's disease. [Eur Neurol. 1998]
Elevated plasma levels of homocysteine in Parkinson's disease.
Kuhn W, Roebroek R, Blom H, van Oppenraaij D, Przuntek H, Kretschmer A, Büttner T, Woitalla D, Müller T. Eur Neurol. 1998 Nov; 40(4):225-7.
Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease. [Neurosci Lett. 1990]
Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease.
Heafield MT, Fearn S, Steventon GB, Waring RH, Williams AC, Sturman SG. Neurosci Lett. 1990 Mar 2; 110(1-2):216-20.
Plasma levels of inorganic sulfates in patients with Parkinson's disease. [Acta Neurol Scand. 1995]
Plasma levels of inorganic sulfates in patients with Parkinson's disease.
Jiménez-Jiménez FJ, Molina JA, Aguilar MV, Jorge-Santamaría A, Mateos-Vega CJ, González-Muñoz MJ, Cabrera-Valdivia F, Ayuso-Peralta L, Benito J, Vázquez A. Acta Neurol Scand. 1995 Nov; 92(5):369-71.
Review Role of lifestyle factors on plasma homocysteine levels in Parkison's disease patients treated with levodopa. [Nutr Neurosci. 2006]
Review Role of lifestyle factors on plasma homocysteine levels in Parkison's disease patients treated with levodopa.
Siniscalchi A, Gallelli L, Mercuri NB, Ibbadu GF, De Sarro G. Nutr Neurosci. 2006 Feb-Apr; 9(1-2):11-6.
Review Is the deficiency of vitamin B12 related to oxidative stress and neurotoxicity in Parkinson's patients? [CNS Neurol Disord Drug Targets...]
Review Is the deficiency of vitamin B12 related to oxidative stress and neurotoxicity in Parkinson's patients?
Qureshi GA, Qureshi AA, Devrajani BR, Chippa MA, Syed SA. CNS Neurol Disord Drug Targets. 2008 Feb; 7(1):20-7.

See reviews... See all...

Cited by 3 PubMed Central articles

Biochemical and computational approaches to improve the clinical treatment of dopa decarboxylase-related diseases: an overview. [Open Biochem J. 2012]
Biochemical and computational approaches to improve the clinical treatment of dopa decarboxylase-related diseases: an overview.
Cellini B, Montioli R, Oppici E, Voltattorni CB. Open Biochem J. 2012; 6:131-8. Epub 2012 Dec 11.
Identification by virtual screening and in vitro testing of human DOPA decarboxylase inhibitors. [PLoS One. 2012]
Identification by virtual screening and in vitro testing of human DOPA decarboxylase inhibitors.
Daidone F, Montioli R, Paiardini A, Cellini B, Macchiarulo A, Giardina G, Bossa F, Borri Voltattorni C. PLoS One. 2012; 7(2):e31610. Epub 2012 Feb 23.
Possible treatment concepts for the levodopa-related hyperhomocysteinemia. [Cardiovasc Psychiatry Neurol. ...]
Possible treatment concepts for the levodopa-related hyperhomocysteinemia.
Müller T. Cardiovasc Psychiatry Neurol. 2009; 2009:969752. Epub 2009 Sep 9.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Sulfate and cysteine levels in the plasma of patients with Parkinson's disease.
Sulfate and cysteine levels in the plasma of patients with Parkinson's disease.
Neurotoxicology. 1995 Fall ;16(3):527-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: